Intellectual Property

  • August 31, 2026

    Judge Trims Claims In Insurance Software Trade Secret Case

    A federal judge in Chicago on Monday issued a mixed ruling in a case brought by a company that makes insurance agency management software against a rival that it claims created a fake insurance company to steal trade secrets, dismissing some claims but preserving others for trade secret misappropriation and violations of the Computer Fraud and Abuse Act.

  • August 31, 2026

    Ford, Bronco Builder Rev Up TM Fight Over Custom Builds

    Ford Motor Co. and a custom Bronco builder are trying to pare down their trademark fight in dueling summary judgment bids, with Ford targeting defenses to its claims over Bronco-inspired SUVs and the defendants accusing the automaker of improperly renewing its Bronco registration while the model was out of production.

  • August 31, 2026

    Fed. Circ. Upholds Block On MSN Cancer Drug In Exelixis Win

    The Federal Circuit on Monday rejected MSN Laboratories' argument that three Exelixis patents on the blockbuster cancer drug Cabometyx are invalid, while dismissing as moot an appeal on a fourth patent, a ruling Exelixis said will block MSN's generic version until 2030.

  • August 31, 2026

    Sony, Warner Music Sue Anthropic Over 'Brazen' IP Theft

    Sony Music and Warner Chappell Music have accused Anthropic in California federal court of carrying out a "brazen campaign" of musical composition theft, alleging the Claude-maker stole lyrics and sheet music by scraping websites, exploiting datasets and "destructively scanning" physical copies of copyrighted music.

  • August 31, 2026

    Juul Sublicense Ends Reynolds' Altria Vape Royalty Tab

    A sublicensing agreement between R.J. Reynolds Vapor Co. and Juul Labs Inc. relieves Reynolds of its obligation to pay ongoing royalties to Philip Morris parent company Altria Client Services LLC after a federal jury found that Reynolds infringed Altria's vape pen design, a North Carolina federal judge has ruled.

  • August 31, 2026

    Ramey Wants Full Fed. Circ. To Reconsider $207K Sanctions

    William Ramey of Ramey LLP has urged the full Federal Circuit to review his liability for more than $207,000 in sanctions in a client's patent infringement suit against Volkswagen, arguing that his notices of appeal were faulty but still adequately identified him as a party.

  • August 31, 2026

    Kioxia Seeks To Undo 'Tainted' $229M Viasat IP Verdict

    Kioxia Corp. urged a Texas federal court Friday to throw out a $229 million patent verdict for Viasat Inc. and order a new trial or grant it a win, arguing that "numerous errors tainted the jury's award."

  • August 31, 2026

    Fed. Circ. Affirms Samsung Didn't Infringe Mobile Tech Patent

    The Federal Circuit on Monday upheld a lower court's decision to deny a new trial in a case accusing Samsung of infringing a mobile device technology patent, saying Samsung had shown "ample" evidence cutting against infringement.

  • August 31, 2026

    Ex-Blanche, Bondi Aide To Join Boies Schiller In DC

    A former chief of staff at the U.S. Attorney General's Office for both Todd Blanche and Pam Bondi is joining Boies Schiller Flexner as a partner in Washington, D.C., the firm announced Monday.

  • August 31, 2026

    Fed. Circ. OKs PTAB Axing Some SpaceTime3D Claims

    The Federal Circuit on Monday affirmed a pair of rulings from the Patent Trial and Appeal Board that found two patents and some claims in a third patent covering graphical user interface technology held by SpaceTime3D Inc. were unpatentable, siding with challenges made by Apple and Google.

  • August 31, 2026

    $60K Default Award Recommended In Book Copying Suit

    A Colorado federal magistrate judge recommended awarding a Romanian publisher $60,000 in statutory damages and permanently barring a Colorado company from infringing its copyrights in two health and wellness books, finding the infringement was willful and continued even after the company defaulted in the case.

  • August 28, 2026

    'Troubled' 7th Circ. Finds No Harm From Benesch Atty Conflict

    While "troubled" by an ex-Benesch Friedlander Coplan & Aronoff LLP partner's decision to take on a client's trade secrets suit while negotiating a move from Benesch to the defendant company's outside counsel, the Seventh Circuit agreed Friday that the displeased client cannot pursue her legal malpractice claim.

  • August 28, 2026

    Patent Marking Case Will Shape License Talks And Damages

    A Federal Circuit ruling that patent owners must ensure that all licensees mark their products with patent information in order to recover presuit damages will complicate licensing talks and give defendants a route to limit or escape damages in some cases, attorneys say.

  • August 28, 2026

    AbbVie 'Concocted' Cancer Drug IP Claims, Biotech Firm Says

    Biotech firms ProfoundBio and Genmab urged a Seattle federal judge Thursday to throw out rival AbbVie's lawsuit accusing two of its former employees of taking trade secrets on cancer therapies to ProfoundBio, arguing AbbVie's claims are time-barred, and the information wasn't a protectable trade secret.

  • August 28, 2026

    'Friday The 13th' Creators Say Game Publisher Hid Royalties

    Creators of the "Friday the 13th" franchise alleged in a Friday suit that a video game publisher withheld up to $4.5 million in royalties from sales of a "Friday the 13th" video game that it was licensed to distribute and destroyed reports that proved how much it owed.

  • August 28, 2026

    American Airlines Can't Shake Intellectual Ventures IP Suit

    A Texas federal judge declined Friday to toss a patent infringement suit against American Airlines over in-flight Wi-Fi, finding the patent licensing company Intellectual Ventures has made enough of a case for the suit to proceed.

  • August 28, 2026

    Apple Is Infringing 5G Tech Patents, Longhorn Affiliate Says

    Apple was hit with a patent suit in Texas federal court Friday by a Longhorn IP affiliate alleging the Silicon Valley tech behemoth is infringing its innovative 5G wireless technologies that are found in some of the defendant's iPhones and iPads.

  • August 28, 2026

    Judge Upholds Robert Bosch Victory In Fuel Patent Trial

    A Texas federal judge has refused to grant a Canadian fuel system company a new trial in its patent infringement case against engineering firm Robert Bosch, saying the company had not met the high standard to overturn a jury verdict.

  • August 28, 2026

    Lamar Jackson's Post-MVP Success Can't Save 'Era 8' TM Bid

    The Trademark Trial and Appeal Board has blocked Baltimore Ravens quarterback Lamar Jackson's bid to register "Era 8 By Lamar Jackson" for clothing and bags, citing a prior default and his failure to use the mark on the bags when he filed his application.

  • August 28, 2026

    Samsung Secures Invalidity Ruling In Mullen Patent Suit

    A Texas federal judge on Friday put an end to a suit alleging that the location-based services on Samsung mobile devices infringe Mullen Industries patents, agreeing with a magistrate judge's determination that the patents were invalid.

  • August 28, 2026

    Trader Joe's Must Face Smucker's TM Suit Over Uncrustables

    Trader Joe's will have to face Smucker's trademark infringement suit accusing the retailer of swiping its intellectual property to market its own copycat version of crustless PB&J sandwiches, after an Ohio federal judge ruled Friday the plaintiff "sufficiently pled fame to survive a motion to dismiss." 

  • August 28, 2026

    Fed. Circ. Shifts T-Mobile Patent Settlement Fight To 5th Circ.

    The Federal Circuit on Friday sent an appeal from T-Mobile stemming from a patent litigation settlement to the Fifth Circuit, ruling that is proper because the Eastern District of Texas had jurisdiction when the appeal was filed.

  • August 28, 2026

    ITC Probes If Apple Stole Tech For Swapping Contact Info

    The U.S. International Trade Commission is investigating a claim that Apple's smart devices infringe a patent covering exchanges of contact information, but a judge will first determine whether the company bringing the claim has sufficient U.S. presence, the agency said Friday.

  • August 28, 2026

    Uber Cars Not Enough To Establish Venue, Judge Says

    A Texas federal magistrate judge has recommended tossing patent infringement claims against Uber Technologies Inc., saying ride-hailing drivers' homes and cars being based in the district was not enough to establish jurisdiction over the company.

  • August 28, 2026

    Buchalter Adds Litigator In Atlanta From Chamberlain Hrdlicka

    Buchalter PC has added a former Chamberlain Hrdlicka White Williams & Aughtry shareholder in its Atlanta office, strengthening its litigation practice with an attorney with significant experience representing businesses in commercial litigation and creditor rights matters, according to an announcement Friday.

Expert Analysis

  • Fed. Circ. Licensing Rulings Shed Light On Patentee Standing

    Author Photo

    Two recent decisions from the Federal Circuit provide a useful framework for evaluating whether a patent license agreement preserves a sufficient exclusionary interest to support future patent infringement claims, say attorneys at Venable.

  • Protecting Quantum Innovation As The Sector Commercializes

    Author Photo

    As quantum technologies continue to attract growing commercial investment and government interest, intellectual property protection is becoming an increasingly important consideration, says Michael Schallop at Van Pelt Yi.

  • Series

    Being A Magician Makes Me A Better Lawyer

    Author Photo

    The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

  • Who Owns The Data Behind The Beautiful Game?

    Author Photo

    Every match at the 2026 FIFA World Cup generates enormous volumes of information that can improve performance, enhance fan engagement and create new revenue streams, but that same data can also create significant legal exposure if rights and responsibilities are not clearly defined, say attorneys at Morgan Lewis.

  • Reel Justice: 'Obsession' And The Importance Of Precision

    Author Photo

    In “Obsession,” the main character’s failure to define the limits of his wish results in an unexpectedly horrifying outcome, highlighting for attorneys why careful word choice is essential not only in briefs, but also in charging decisions, statutory interpretation and all stages of criminal litigation, says Veronica Finkelstein at Widener-Delaware Law.

  • How Pfizer Won Fed. Circ. Patent Dispute By 1 Carbon Atom

    Author Photo

    The Federal Circuit's recent refusal to revive a patent in Enanta Pharmaceuticals v. Pfizer over an alleged typo creating a one-atom difference in a COVID-19 treatment application hands defendants a template for potentially converting a triable fact question into an early dispositive ruling, say attorneys at Polsinelli.

  • Fed. Circ. Ruling Highlights The Cost Of Incorrect Inventorship

    Author Photo

    The Federal Circuit's recent decision in Fortress Iron v. Digger Specialties, affirming that a fencing company's patents were invalid due to a missing co-inventor, is a reminder that confirming correct inventorship should be a critical part of every patent invalidity workup, say attorneys at Neal Gerber.

  • Shopify Settlement Clouds Open-Source Copyright Limits

    Author Photo

    Shopify's confidential copyright settlement with Shopline, which agreed to stop distributing a disputed storefront theme, raises questions about how far copyright law can protect open-source software without undermining the collaboration that drives development, says Lindsey Sasson at Hach Rose.

  • What Data Says About Biologics-Related Ex Parte Challenges

    Author Photo

    An analysis of the 67 ex parte reexaminations used to challenge biologics patents over the last 13 years reveals that reexamination may emerge as an alternative to inter partes review and postgrant review, despite facing a number of procedural disadvantages, say attorneys at Steptoe.

  • CFIUS' Mandate Misses Foreign Risk In Project Subcontracts

    Author Photo

    Recent calls for the Committee on Foreign Investment in the United States to review equity transactions like the Paramount Skydance-Warner Bros. deal miss a consequential oversight gap — CFIUS' inability to review the subcontracting layer of U.S. infrastructure projects, says Thibaut Giret at Alstef Group.

  • Looking At Drake's Diss Track Appeal Through An IP Lens

    Author Photo

    Though Drake's pending Second Circuit appeal over UMG's promotion of Kendrick Lamar's "Not Like Us" is formally about defamation, it shows that IP considerations can help identify records showing how a work traveled, which may guide courts when deciding context, says attorney Abdul Abdullahi.

  • Series

    Bass Fishing Makes Me A Better Lawyer

    Author Photo

    Landing a trophy striped bass and closing a big deal both require cultivating the patience to finesse — not force — your way to desired outcomes, changing course when your old approach isn’t working and learning from the ones that got away, says Jon Ruiss at Alston & Bird.

  • Roundup

    The Most Talked-About Supreme Court Decisions Of 2026

    Author Photo

    This term, 11 U.S. Supreme Court decisions quickly became hot topics among Law360's guest writers.

  • Fighting The Evidentiary Risks Of Deepfakes In Court

    Author Photo

    Though courts and federal rules are only slowly developing frameworks for assessing digital evidence that could have been created or generated by artificial intelligence, litigators should understand what steps they'll likely need to take to successfully challenge potentially deepfaked exhibits — and fight questions about the authenticity of their own, say attorneys at MoFo.

  • Coordinating Life Sciences IP Strategies In The US And EU

    Author Photo

    As postgrant practice for life sciences patents is restructured in the U.S. and European Union simultaneously, patent owners will need to implement transatlantic coordination that treats international proceedings as components of a single intellectual property risk architecture, says Paul Calvo at Sterne Kessler.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.